The Display Technologies team uses in vitro recombinant technologies such as phage display as a powerful platform for the discovery of candidates suitable for drug development. We enable the identification of a broad range of biologics, including antibodies, with the ability to engineer many of the attributes of successful drugs. We generate highly diverse display libraries and build machine-learning designed libraries.

Recent projects include reducing our reliance on out-sourced phage display work by generating our own in-house novel phage and ML designed libraries.